Cheng Yi Pharma(SH:603811) Zheng Quan Zhi Xing·2025-09-01 11:08Overview - Zhejiang Chengyi Pharmaceutical Co., Ltd. has received the drug registration certificate for Eicosapentaenoic Acid Ethyl Ester Soft Capsules from the National Medical Products Administration [1][2] Drug Information - The drug is approved for use in lowering triglyceride levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL) and is indicated for use in conjunction with statins for patients with cardiovascular disease or diabetes with multiple cardiovascular risk factors [1] - The drug has been classified as a Class 4 chemical drug and is considered to have passed the consistency evaluation for generic drugs [2] Company Impact - The company has invested a total of 15.603 million yuan in the research and development of Eicosapentaenoic Acid Ethyl Ester Soft Capsules [2]